Keywords: AD; Alzheimer's disease; AGEs; advanced glycation end products; BBB; blood-brain barrier; BDNF; brain-derived nerve growth factor; CML; carboxymethyllysine; CMRg; cerebral metabolic rate of glucose; DAMPs; damage-associated molecular patterns; GLUT; gluco
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AD; Alzheimer's disease; T2DM; type II diabetes mellitus; Aβ; amyloid beta; NFT; neurofibrillary tangles; IR; insulin resistance; InsR; insulin receptors; IRS; InsR substrate; IGF; insulin growth factor; ICV; intracerebroventricular; STZ; streptozotocin;
Keywords: AGEs; advanced glycation end-products; RAGE; receptor for AGEs; ROS; reactive oxygen species; NAFLD; non-alcoholic fatty liver disease; MCD; methionine choline deficient; MCR; methionine choline replete; CML; N-(carboxymethyl)lysine; ALT; alanine transami
The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophrenia
Keywords: Carbonyl stress; Advanced glycation end-products (AGEs); Receptor for AGEs (RAGE); Endogenous secretory RAGE (esRAGE); Soluble RAGE (sRAGE); Schizophrenia; AGEs; advanced glycation end-products; RAGE; receptor for AGEs; esRAGE; endogenous secretory RAGE;
Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta
Keywords: AGEs; RAGE; Oxidative stress; Sulforaphane; Atherosclerosis; AGEs; advanced glycation end products; RAGE; receptor for AGEs; Nrf2; nuclear factor erythroid-related factor 2; EC; endothelial cell; HUVECs; human umbilical vein ECs; BSA; bovine serum albumin
Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway
Keywords: Aβ; β-amyloid; Aβ-AGE; glycated Aβ; AD; Alzheimer's disease; AGEs; advanced glycation end-products; AP; anterior to posterior; APP; amyloid precursor protein; DV; dorsal to ventral; EDTA; ethylenediaminetetraacetic acid; EPSP; excitatory postsynapti
A novel high resolution MS approach for the screening of 4-hydroxy-trans-2-nonenal sequestering agents
Keywords: RCS; reactive carbonyl species; AGEs; advanced glycoxidation end products; ALEs; advanced lipoxidation end products; RAGE; receptor for AGEs; HNE; 4-hydroxy-2-nonenal; LE; procyanidins form Vitis vinifera; GCB; green coffee bean extract; Reactive carbonyl
Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level
Keywords: AGEs; advanced glycation end products; RAGE; receptor for AGEs; CKD; chronic kidney disease; ROS; reactive oxygen species; BSA; bovine serum albumin; GGPP; geranylgeranyl pyrophosphate; Ab; antibody; ADMA; asymmetric dimethylarginine; RAGE-Ab; Ab raised a
Aminoguanidine normalizes ET-1-induced aortic contraction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats by suppressing Jab1-mediated increase in ETA-receptor expression
Keywords: AG; aminoguanidine; AGEs; advanced glycation end-products; CML; N epsilon-(carboxymethyl) lysine; ECE1; endothelin converting enzyme; ERK; extracellular signal-regulated kinase; ET-1; endothelin-1; ETA-R; endothelin type A receptor; ETB-R; endothelin type
Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: Role of macrophage scavenger receptor class A type I and II
Keywords: Food allergy; food allergen; Maillard reaction; T-cell immunogenicity; dendritic cells; macrophage scavenger receptor; AGE; Advanced glycation end product; APC; Antigen-presenting cell; CEL; Nε-carboxyethyl-lysine; CFSE; Carboxyfluorescein succinimidyl e
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension
Keywords: AGEs; advanced glycation end products; RAGE; receptor for AGEs; ECs; endothelial cells; RAS; renin-angiotensin system; ACE; angiotensin-converting enzyme; Ang II; angiotensin II; ARBs; Ang II type 1 receptor blockers; ICAM-1; intracellular adhesion mole
Two analytical methods to study the interaction of AGEs with cell surface proteins
Keywords: AGEs; Advanced glycation end products; BSA; Bovine serum albumin; CEA; Chicken egg albumin; DMEM; Dubelco's modified eagle's medium; 2,4-DNPH; 2,4-Dinitrophenyl hydrazine; ESI; Electrospray ionization; HSA; Human serum albumin; FCS; Foetal calf serum; FIT